The cosmetic surgery market would grow at a CAGR of 12.42% over the predicted time frame. The market is expected to increase in value from US$ 80.38 Bn in 2022 to US$ 205.1Bn in 2030.
The on cosmetic surgery Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/2083
Report Scope of the Cosmetic Surgery Market
| Report Coverage | Details |
| Market Size in 2022 | USD 80.38 Billion |
| Market Size by 2030 | USD 205.1 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 12.42% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Procedure, Gender, Age, End User, and Geography |
| Companies Mentioned | Evolus Inc., RevanceGalderma, AbbVie, Cynosure, Lumenis, Solta Medical, Alma Laser, Syneron Candela. |
A recent report provides crucial insights along with application based and forecast information in the Global Cosmetic surgery Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Cosmetic surgery market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Cosmetic surgery market are included as given below:
Cosmetic surgery Market Key Players
- Evolus Inc.
- RevanceGalderma
- AbbVie
- Cynosure
- Lumenis
- Solta Medical
- Alma Laser
- Syneron Candela
Market Segments
By Procedure
- Surgical Procedures
- Breast Augmentation
- Liposuction
- Eyelid Surgery
- Abdominoplasty
- Rhinoplasty
- Others
- Non-surgical Procedures
- Botulinum Toxin
- Hyaluronic Acid
- Hair Removal
- Nonsurgical Fat Reduction
- Photo Rejuvenation
- Others
By Gender
- Male
- Female
By Age
- 13 - 29
- 30 - 54
- 55 plus
By End User
- Ambulatory Surgical Facility
- Hospital and Clinic
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, describe, and forecast the global cosmetic surgery market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the cosmetic surgery market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cosmetic Surgery Market
5.1. COVID-19 Landscape: Cosmetic Surgery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cosmetic Surgery Market, By Procedure
8.1. Cosmetic Surgery Market, by Procedure, 2022-2030
8.1.1. Surgical Procedures
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Non-surgical Procedures
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Cosmetic Surgery Market, By Gender
9.1. Cosmetic Surgery Market, by Gender, 2022-2030
9.1.1. Male
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Female
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Cosmetic Surgery Market, By Age
10.1. Cosmetic Surgery Market, by Age, 2022-2030
10.1.1. 13 - 29
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. 30 - 54
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. 55 plus
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Cosmetic Surgery Market, By End User
11.1. Cosmetic Surgery Market, by End User, 2022-2030
11.1.1. Ambulatory Surgical Facility
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Hospital and Clinic
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Cosmetic Surgery Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.1.2. Market Revenue and Forecast, by Gender (2017-2030)
12.1.3. Market Revenue and Forecast, by Age (2017-2030)
12.1.4. Market Revenue and Forecast, by End User (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Gender (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Age (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Gender (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Age (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.2.2. Market Revenue and Forecast, by Gender (2017-2030)
12.2.3. Market Revenue and Forecast, by Age (2017-2030)
12.2.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Gender (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Age (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Gender (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Age (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Gender (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Age (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Gender (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Age (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.3.2. Market Revenue and Forecast, by Gender (2017-2030)
12.3.3. Market Revenue and Forecast, by Age (2017-2030)
12.3.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Gender (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Age (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Gender (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Age (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Gender (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Age (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Gender (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Age (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.4.2. Market Revenue and Forecast, by Gender (2017-2030)
12.4.3. Market Revenue and Forecast, by Age (2017-2030)
12.4.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Gender (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Age (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Gender (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Age (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Gender (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Age (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Gender (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Age (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.5.2. Market Revenue and Forecast, by Gender (2017-2030)
12.5.3. Market Revenue and Forecast, by Age (2017-2030)
12.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Gender (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Age (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Gender (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Age (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End User (2017-2030)
Chapter 13. Company Profiles
13.1. Evolus Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. RevanceGalderma
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. AbbVie
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Cynosure
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Lumenis
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Solta Medical
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Alma Laser
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Syneron Candela
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments